Nanoform has appointed Henri von Haartman as Director of Investor Relations. The newly created role will enrich investor relations as Nanoform seeks to further its shareholder base and continue its international growth, including expansion into the US market.
Nanoform announced the completion of a private placement totaling €10 million, with Ilmarinen Mutual Pension Insurance Company and Mandatum Life Insurance Company (Sampo Group) acting as anchor investors.
Nanoform has unveiled a new brand identity and website. The evolution of Nanoform’s brand reflects how the company is using innovation to transform the pharmaceutical industry and support its global partners as they develop life-changing medicines.
Our CBO, Gonçalo Rebelo de Andrade, discusses the advantages offered…
Our CCO, Christian Jones, recently discussed the advantages of our nanonization services with Mike Ward at EBD Group’s BIO-Europe Spring 2019. Watch the Scrip video to learn more:
Our CTO, Niklas Sandler, explains how our innovative use of…
Nanoform accelerates growth with Director of Project Management appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, will appoint Miguel Cansado as its Director of Project Management.